Bridges TM; Marlo JE; Niswender CM; et al. (2009). „Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins”. J. Med. Chem. 52 (11): 3445—8. PMID19438238. doi:10.1021/jm900286j.CS1 одржавање: Експлицитна употреба et al. (веза)
Grant MK, El-Fakahany EE (2005). „Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor”. J. Pharmacol. Exp. Ther. 315 (1): 313—9. PMID16002459. doi:10.1124/jpet.105.090134.
nih.gov
ncbi.nlm.nih.gov
Bridges TM; Marlo JE; Niswender CM; et al. (2009). „Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins”. J. Med. Chem. 52 (11): 3445—8. PMID19438238. doi:10.1021/jm900286j.CS1 одржавање: Експлицитна употреба et al. (веза)
Grant MK, El-Fakahany EE (2005). „Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor”. J. Pharmacol. Exp. Ther. 315 (1): 313—9. PMID16002459. doi:10.1124/jpet.105.090134.